Farxiga

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Farxiga’s approval for expanded use highlights potential to differentiate in HF space
Clinical Trials Arena
Fri, 05/12/23 - 11:42 am
AstraZeneca
Farxiga
heart failure
Farxiga Approval Expands Use to More Patients With Heart Failure
eMPR
Tue, 05/9/23 - 11:28 pm
AstraZeneca
Farxiga
FDA
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Eli Lilly
Boehringer Ingelheim
chronic kideny disease
Jardiance
Farxiga
AstraZeneca
AstraZeneca’s Farxiga reduces CV mortality risk in Phase III trials
Clinical Trials Arena
Mon, 08/29/22 - 11:01 am
AstraZeneca
Farxiga
clinical trials
heart failure
AZ bites back at rivals with new Farxiga data in heart failure
Pharmaforum
Thu, 05/5/22 - 10:16 am
AstraZeneca
Farxiga
heart failure
clinical trials
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
Europe
AstraZeneca
Farxiga
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga
Farxiga faces first heart failure rival as EU OKs Boehringer/Lilly’s Jardiance
Pharmaforum
Wed, 06/23/21 - 10:59 am
AstraZeneca
Farxiga
heart failure
Boehringer Ingelheim
Eli Lilly
Jardiance
ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it’s safe for them to use
Fierce Pharma
Sun, 05/16/21 - 11:22 pm
AstraZeneca
Farxiga
COVID-19
Bayer's near-approval Farxiga rival meets goal in 2nd phase 3
Fierce Biotech
Mon, 05/10/21 - 10:03 am
Bayer
finerenone
Farxiga
clinical trials
cardiovascular disease
myocardial infarction
AstraZeneca's big CKD promises come to fruition as Farxiga wins approval in patients regardless of diabetes status
Endpoints
Mon, 05/3/21 - 10:45 am
AstraZeneca
Farxiga
FDA
chronic kidney disease
AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance
Fierce Pharma
Sat, 05/1/21 - 09:23 pm
AstraZeneca
chronic kidney disease
FDA
Farxiga
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
Pharmaforum
Mon, 04/12/21 - 10:33 am
AstraZeneca
diabetes
heart failure
Farxiga
COVID-19
clinical trials
AstraZeneca's Farxiga gets rough FDA review date for groundbreaking move into chronic kidney disease
Endpoints
Wed, 01/6/21 - 11:03 am
AstraZeneca
Farxiga
FDA
chronic kidney disease
Bayer faces an uphill fight with finerenone
EP Vantage
Mon, 10/26/20 - 11:13 am
Bayer
diabetic kidney disease
kidney disease
clinical trials
finerenone
Invokana
Farxiga
The FDA hands Farxiga 'breakthrough' status in CKD, clearing path for AstraZeneca's much-touted therapy
Endpoints
Sun, 10/4/20 - 12:18 am
AstraZeneca
chronic kidney disease
FDA
breakthrough therapy
Farxiga
ESC 2020 – Farxiga impresses in chronic kidney disease
EP Vantage
Mon, 08/31/20 - 10:14 am
ESC
Farxiga
chronic kidney disease
diabetes
clinical trials
AstraZeneca
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
EP Vantage
Mon, 08/31/20 - 10:13 am
ESC
Eli Lilly
Boehringer Ingelheim
Farxiga
Jardiance
heart failure
AstraZeneca
After stopping Farxiga trial early, AstraZeneca declares success in CKD treatment
Endpoints
Tue, 07/28/20 - 11:17 am
AstraZeneca
Farxiga
clinical trials
chronic kidney disease

Pages